These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 25878216)
1. Commentary: Frailty and heterogeneity in epidemiological studies. Moolgavkar SH Int J Epidemiol; 2015 Aug; 44(4):1425-6. PubMed ID: 25878216 [No Abstract] [Full Text] [Related]
2. Commentary: Frailty and cancer. Peto J Int J Epidemiol; 2015 Aug; 44(4):1423-4. PubMed ID: 25842266 [No Abstract] [Full Text] [Related]
3. Commentary: Age and frailty-not quite the same thing. Mathews JD; Hopper JL Int J Epidemiol; 2015 Aug; 44(4):1421-3. PubMed ID: 25855711 [No Abstract] [Full Text] [Related]
4. Understanding variation in disease risk: the elusive concept of frailty. Aalen OO; Valberg M; Grotmol T; Tretli S Int J Epidemiol; 2015 Aug; 44(4):1408-21. PubMed ID: 25501685 [TBL] [Abstract][Full Text] [Related]
5. Authors' response: Understanding variation in disease risk. Aalen OO; Valberg M; Grotmol T; Tretli S Int J Epidemiol; 2015 Aug; 44(4):1426-8. PubMed ID: 25842265 [No Abstract] [Full Text] [Related]
6. Tissue Heterogeneity as a Pre-analytical Source of Variability. Stanta G Recent Results Cancer Res; 2015; 199():35-43. PubMed ID: 25636427 [No Abstract] [Full Text] [Related]
7. The biodemography of variation in human frailty. Weiss KM Demography; 1990 May; 27(2):185-206. PubMed ID: 2332085 [TBL] [Abstract][Full Text] [Related]
8. The end of the beginning: epigenetic variation in utero as a mediator of later human health and disease. Mansell T; Saffery R Epigenomics; 2017 Mar; 9(3):217-221. PubMed ID: 28234019 [No Abstract] [Full Text] [Related]
10. Tumor Heterogeneity in Pancreatic Adenocarcinoma. Cros J; Raffenne J; Couvelard A; Poté N Pathobiology; 2018; 85(1-2):64-71. PubMed ID: 28787741 [TBL] [Abstract][Full Text] [Related]
11. Role of epigenetics in lung cancer heterogeneity and clinical implication. Dong N; Shi L; Wang DC; Chen C; Wang X Semin Cell Dev Biol; 2017 Apr; 64():18-25. PubMed ID: 27575638 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of endothelial cell heterogeneity in health and disease. Aird WC Circ Res; 2006 Feb; 98(2):159-62. PubMed ID: 16456105 [No Abstract] [Full Text] [Related]
13. [Genetic, environmental, and epigenetic contribution to the susceptibility to autism spectrum disorders]. Díaz-Anzaldúa A; Díaz-Martínez A Rev Neurol; 2013 Dec; 57(12):556-68. PubMed ID: 24288105 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological and evolutionary consequences of targeted vaccination. Williams PD; Day T Mol Ecol; 2008 Jan; 17(1):485-99. PubMed ID: 18173510 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity and the design of genetic studies in autism. Sutcliffe JS Autism Res; 2008 Aug; 1(4):205-6. PubMed ID: 19360669 [No Abstract] [Full Text] [Related]
18. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity for multiple disease loci in linkage analysis. Bhat A; Heath SC; Ott J Hum Hered; 1999 Jul; 49(4):229-31. PubMed ID: 10436385 [TBL] [Abstract][Full Text] [Related]
20. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment. Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113 [No Abstract] [Full Text] [Related] [Next] [New Search]